Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Seth Bechis

    TitleAssociate Physician
    SchoolUniversity of California, San Diego
    DepartmentUrology
    Address9300 Campus Point Drive #7897
    CA La Jolla 92037
    vCardDownload vCard

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Wintner A, Kim MM, Bechis S, Kreydin EI. Voiding Dysfunction in Multiple Sclerosis. Semin Neurol. 2016 Apr; 36(2):219-20. PMID: 27116728.
        View in: PubMed
      2. Wintner A, Kim MM, Bechis S, Kreydin EI. Voiding Dysfunction in Multiple Sclerosis. Semin Neurol. 2016 Feb; 36(1):34-40. PMID: 26866494.
        View in: PubMed
      3. Sanchez A, Rodríguez D, Allard CB, Bechis S, Sullivan RJ, Boeke CE, Kuppermann D, Cheng JS, Barrisford GW, Preston MA, Feldman AS. Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort. Urol Oncol. 2016 Apr; 34(4):166.e7-166.e14. PMID: 26739672.
        View in: PubMed
      4. Bechis S, Otsetov AG, Ge R, Wang Z, Vangel MG, Wu CL, Tabatabaei S, Olumi AF. Age and Obesity Promote Methylation and Suppression of 5a-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia. J Urol. 2015 Oct; 194(4):1031-7. PMID: 25916673.
        View in: PubMed
      5. Ge R, Wang Z, Bechis S, Otsetov AG, Hua S, Wu S, Wu CL, Tabatabaei S, Olumi AF. DNA methyl transferase 1 reduces expression of SRD5A2 in the aging adult prostate. Am J Pathol. 2015 Mar; 185(3):870-82. PMID: 25700986; PMCID: PMC4348471 [Available on 03/01/16].
      6. Bechis S, Eisner BH. Editorial comment. Urology. 2014 Sep; 84(3):542-3. PMID: 25168530.
        View in: PubMed
      7. Bechis S, Eisner BH. The STONE score can help diagnose urolithiasis and decrease the use of CT scans. Evid Based Med. 2014 Dec; 19(6):234. PMID: 25053641.
        View in: PubMed
      8. Bechis S, Otsetov AG, Ge R, Olumi AF. Personalized medicine for the management of benign prostatic hyperplasia. J Urol. 2014 Jul; 192(1):16-23. PMID: 24582540; NIHMSID: NIHMS605355.
        View in: PubMed
      9. Bechis S, Carroll PR, Cooperberg MR. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol. 2011 Jan 10; 29(2):235-41. PMID: 21135285; PMCID: PMC3058279.
      10. Eisner BH, Porten SP, Bechis S, Stoller ML. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol. 2010 Jun; 183(6):2244-8. PMID: 20400141.
        View in: PubMed
      11. Eisner BH, Porten SP, Bechis S, Stoller ML. The role of race in determining 24-hour urine composition in white and Asian/Pacific Islander stone formers. J Urol. 2010 Apr; 183(4):1407-11. PMID: 20171692.
        View in: PubMed
      12. Eisner BH, Porten SP, Bechis S, Stoller ML. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol. 2010 Feb; 183(2):576-9. PMID: 20018328.
        View in: PubMed
      13. Kouros-Mehr H, Kim JW, Bechis S, Werb Z. GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol. 2008 Apr; 20(2):164-70. PMID: 18358709; NIHMSID: NIHMS47573.
        View in: PubMed
      14. Kouros-Mehr H, Bechis S, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell. 2008 Feb; 13(2):141-52. PMID: 18242514; NIHMSID: NIHMS40140.
        View in: PubMed
      15. Wei H, Ruthenburg AJ, Bechis S, Verdine GL. Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase. J Biol Chem. 2005 Nov 4; 280(44):37041-7. PMID: 16100112.
        View in: PubMed